News – ACAD

FDA’s Accelerated Approval for Aduhelm

Posted on September 15, 2021September 15, 2021 by Carlos Thomas

This past June, the U.S. Food and Drug Administration approved Aduhelm (aducanumab) for the treatment of Alzheimer’s disease via an Accelerated Approval pathway.

Institutions of ACAD Issue Statements Against Anti-Asian Hate

Posted on April 8, 2021April 13, 2021 by Carlos Thomas

ACAD stands against anti-Asian hate. Please read through the following article for links to the ACAD statement and statements from the ACAD members’ institutions and projects.

ACAD Statement on the Atlanta Shootings on March 16, 2021

Posted on March 20, 2021March 20, 2021 by Carlos Thomas

ACAD releases a statement addressing the tragedy in Atlanta that occurred on March 16, 2021

Happy Lunar New Year!

Posted on February 13, 2021February 13, 2021 by Carlos Thomas

Happy Lunar New Year! From the ACAD Study, we wish you all good health, good fortune, and a prosperous year of the Ox!

In Forbes, ACAD MPI Dr. Park on Korean Drama Research

Posted on February 3, 2021February 3, 2021 by Carlos Thomas

Forbes featured ACAD MPI Dr. Park in an article for her work using Korean dramas as a mental health education tool for Asian Americans.

ACAD’s Statement on President Biden’s Recent Executive Order

Posted on February 2, 2021February 2, 2021 by Briana Vogel

ACAD applauds President Biden’s Executive Order condemning and combating racism, xenophobia, and intolerance against AAPIs.

ACAD Kickoff and Press Release

Posted on February 2, 2021February 2, 2021 by Briana Vogel

The Asian Cohort for Alzheimer’s Disease (ACAD) recently received a pilot grant from the National Institute on Aging. Continue reading for more information and to find Penn Medicine’s press release highlighting the award.